Master’s Degree with a minimum of 5 years’ experience performing next generation sequencing data analysis, bioinformatics tool and pipeline development.
From Versiti, Inc - Sat, 10 Dec 2022 08:48:28 GMT - View all Milwaukee, WI jobs

Notice NOT-ES-23-003 from the NIH Guide for Grants and Contracts

Notice NOT-NS-23-052 from the NIH Guide for Grants and Contracts

Notice NOT-AT-23-005 from the NIH Guide for Grants and Contracts

Notice NOT-DA-23-013 from the NIH Guide for Grants and Contracts

Notice NOT-HL-22-062 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-23-067 from the NIH Guide for Grants and Contracts. The INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project encourages exploratory and innovative research to develop, characterize, or improve animal models and related biological materials for Down syndrome (DS) related research and to improve access to information about or from the use of animal models for DS research. The animal models and related biological materials developed must have utility in targeted or basic science studies in areas highly relevant to DS. With this funding opportunity announcement, the INCLUDE Project encourages, but is not limited to, projects focusing on development of various animal models, genetic resources, atlases at a single cell or subcellular level, advanced informatics technologies including artificial intelligence (AI) or machine learning (ML), and integration of multiple animal models and technology platforms for enhancing rigor and reproducibility of preclinical DS research.

Funding Opportunity RFA-AT-23-008 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support a collection of research networks that promote multidisciplinary mechanistic studies of music-based interventions (MBIs) for pain or Alzheimers disease and Alzheimers disease related dementias (AD/ADRD). These networks are expected to develop compelling research frameworks that will guide future clinical research on MBIs in these health conditions effectively, adopt consistent terminology and taxonomy, support interdisciplinary collaborations, initiate pilot projects testing novel mechanistic hypotheses, and identify strong mechanistic measures, outcomes, biomarkers, as well as relevant novel technologies and methodologies. To accomplish these objectives, applicants can propose activities such as meetings, workshops, conferences, research collaborations, exchange of ideas through visiting scientist arrangements and training opportunities. The research networks would also provide opportunities for development of pilot projects addressing research gaps identified through network meetings and collaborative discussions, providing the necessary preliminary data needed for music and health investigators to compete for more substantial NIH grants. In addition, the networks should also engage in dissemination activities that promote and sustain their scientific impact through publications of research frameworks, common terminologies, reviews, and best practices as well as other outreach and communication strategies.

Notice NOT-OD-23-034 from the NIH Guide for Grants and Contracts

Competitive Salary: F. Hoffmann-La Roche AG: The PositionGenentech, a member of the Roche group and founder of the biotechnology industry, is dedicated to pursuing groundbreaking science to disco San Francisco, California (US)

Notice NOT-CA-23-020 from the NIH Guide for Grants and Contracts

Notice NOT-CA-23-021 from the NIH Guide for Grants and Contracts

Notice NOT-CA-23-019 from the NIH Guide for Grants and Contracts

Notice NOT-NR-23-006 from the NIH Guide for Grants and Contracts

Notice NOT-NS-23-051 from the NIH Guide for Grants and Contracts

Notice NOT-MH-23-120 from the NIH Guide for Grants and Contracts

Notice NOT-CA-23-022 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-23-042 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) participating Institutes and Centers (ICs), in collaboration with the Global Alliance for Chronic Diseases (GACD), invite applications for implementation research focused on addressing risk factors for common noncommunicable diseases (NCDs) in World Bank-defined low- and middle-income countries (LMICs) and American Indian/Alaska Native (AI/AN) Tribal Nation populations in the United States. This Funding Opportunity Announcement (FOA) supports innovative approaches to identifying, understanding, developing, and implementingstrategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, tools, policies, and guidelines. In addition, studies to advance dissemination and implementation research methods and measures into application are encouraged. Specifically, this FOA invites applications that propose implementation research targeted to reducing the risks of NCDs in the context of cities in LMICs and/or among AI/AN Tribal Nation populations in cities in the United States, with the potential to equip policymakers and practitioners with evidence-based strategies for prevention and/or management of NCDs among disadvantaged populations globally. In the context of this FOA, "cities" include urban centers, informal settlements and slums, and periurban areas.

Funding Opportunity PAR-23-043 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) participating Institutes and Centers (ICs), in collaboration with the Global Alliance for Chronic Diseases (GACD), invite applications for implementation research focused on addressing risk factors for common noncommunicable diseases (NCDs) in World Bank-defined low- and middle-income countries (LMICs) and American Indian/Alaska Native (AI/AN) Tribal Nation populations in the United States. This Funding Opportunity Announcement (FOA) supports innovative approaches to identifying, understanding, developing, and implementing strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, tools, policies, and guidelines. In addition, studies to advance dissemination and implementation research methods and measures into application are encouraged. Specifically, this FOA invites applications that propose implementation research targeted to reducing the risks of NCDs in the context of cities in LMICs and/or among AI/AN Tribal Nation populations in cities in the United States, with the potential to equip policymakers and practitioners with evidence-based strategies for prevention and/or management of NCDs among disadvantaged populations globally. In the context of this FOA, "cities" include urban centers, informal settlements and slums, and periurban areas. This FOA uses the bi-phasic, milestone driven R61/R33 grant mechanism. Awards made under this FOA will initially support a two-year milestone-driven initiation (R61) phase, with possible transition to an implementation (R33) phase of up to 3 additional years. Only projects that meet the scientific milestones and award requirements of the R61 phase may transition to the R33 phase. Applications submitted in response to this FOA must address both the R61 and R33 phases.

As a member of the bioinformatics team and in this new role you will develop robust analytical pipelines for analysis of a wide range of next generation…
From Cellular Dynamics - Wed, 07 Dec 2022 05:26:43 GMT - View all Madison, WI jobs